Harrow Health Inc (NASDAQ:HROW)

5.86
Delayed Data
As of Sep 25
 +0.32 / +5.78%
Today’s Change
3.33
Today|||52-Week Range
7.92
-24.68%
Year-to-Date
Harrow Health Inc (HROW) Investor Presentation - Slideshow
Sep 18 / Seeking Alpha - Paid Partner Content
Our Take On Eton Pharmaceuticals
Sep 01 / Seeking Alpha - Paid Partner Content
Harrow Health's Shares March Higher, Can It Continue?
Sep 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close5.54
Today’s open5.68
Day’s range5.54 - 5.73
Volume6,998
Average volume (3 months)185,117
Market cap$150.6M
Data as of 3:59pm ET, 09/25/2020

Growth & Valuation

Earnings growth (last year)-99.01%
Earnings growth (this year)-370.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+23.67%
P/E ratioNM
Price/Sales4.02
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
AVEOAveo Pharmaceuticals...+0.22+3.89%
SESNSesen Bio Inc+0.07+5.69%
SLNOSoleno Therapeutics ...+0.04+2.21%
CRHMCRH Medical Corp-0.05-2.36%
Data as of 3:59pm ET, 09/25/2020

Financials

Next reporting dateNovember 17, 2020
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$51.2M
Annual profit (last year)$168.0K
Net profit margin0.33%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Nashville, Tennessee

Forecasts